These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32729905)

  • 21. Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.
    Roukens AHE; van Halem K; de Visser AW; Visser LG
    Ann Intern Med; 2018 Dec; 169(11):761-765. PubMed ID: 30476963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of two yellow fever vaccines for routine immunization programs in Argentina.
    Ripoll C; Ponce A; Wilson MM; Sharif N; Vides JB; Armoni J; Teuwen DE
    Hum Vaccin; 2008; 4(2):121-6. PubMed ID: 18382132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of yellow fever vaccine administration in confirmed egg-allergic patients.
    Gerhardt CMB; Castro APBM; Pastorino AC; Dorna MB; Nunes-Santos CJ; Aquilante BP; Miyaji KT; Lopes MH
    Vaccine; 2020 Sep; 38(42):6539-6544. PubMed ID: 32829980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group].
    Martinho C; Lopes D; Bastos L; Esteves H
    Acta Med Port; 2018 Dec; 31(12):724-729. PubMed ID: 30684369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Vaccine; 2011 Jun; 29(28):4544-55. PubMed ID: 21549787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.
    Collaborative group for studies on yellow fever vaccines
    Vaccine; 2019 Aug; 37(35):5129-5135. PubMed ID: 31171393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases.
    Pileggi GS; Da Mota LMH; Kakehasi AM; De Souza AW; Rocha A; de Melo AKG; da Fonte CAM; Bortoletto C; Brenol CV; Marques CDL; Zaltman C; Borba EF; Reis ER; Freire EAM; Klumb EM; Christopoulos GB; Laurindo IMM; Ballalai I; Da Costa IP; Michelin L; de Azevêdo Valadares LD; Chebli LA; Lacerda M; Toscano MAF; Yazbek MA; De Abreu Vieira RMR; Magalhães R; Kfouri R; Richtmann R; Merenlender SDCS; Valim V; De Assis MR; Kowalski SC; Trevisani VFM
    Adv Rheumatol; 2019 Apr; 59(1):17. PubMed ID: 31036077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long term persistence of yellow fever neutralising antibodies in elderly persons].
    Coulange Bodilis H; Benabdelmoumen G; Gergely A; Goujon C; Pelicot M; Poujol P; Consigny PH
    Bull Soc Pathol Exot; 2011 Oct; 104(4):260-5. PubMed ID: 21336654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The elderly, the young and the pregnant traveler -- A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination.
    Jaeger VK; Tschudi N; Rüegg R; Hatz C; Bühler S
    Travel Med Infect Dis; 2015; 13(6):475-84. PubMed ID: 26526774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
    Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?
    Thomas RE; Spragins W; Lorenzetti DL
    Vaccine; 2013 Dec; 31(52):6201-9. PubMed ID: 24436960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with yellow fever vaccine failure: A systematic literature review.
    Fantinato FFST; Wachira VK; Porto VBG; Peixoto HM; Duarte EC
    Vaccine; 2023 Mar; 41(13):2155-2169. PubMed ID: 36841725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of yellow fever vaccine in Indian travellers: A prospective observational study.
    Tiwari P; Ahlawat R; Gupta G
    Indian J Med Res; 2016 Nov; 144(5):778-780. PubMed ID: 28361832
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
    Campi-Azevedo AC; Peruhype-Magalhães V; Coelho-Dos-Reis JG; Costa-Pereira C; Yamamura AY; Lima SMB; Simões M; Campos FMF; de Castro Zacche Tonini A; Lemos EM; Brum RC; de Noronha TG; Freire MS; Maia MLS; Camacho LAB; Rios M; Chancey C; Romano A; Domingues CM; Teixeira-Carvalho A; Martins-Filho OA;
    J Immunol Methods; 2017 Sep; 448():9-20. PubMed ID: 28514646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study.
    Azevedo LS; Lasmar EP; Contieri FL; Boin I; Percegona L; Saber LT; Selistre LS; Netto MV; Moreira MC; Carvalho RM; Bruno RM; Ferreira TC; David-Neto E
    Transpl Infect Dis; 2012 Jun; 14(3):237-41. PubMed ID: 22093046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases.
    Emi Aikawa N; Andrade Balbi V; Borba EF; Coracini Tonacio A; Maluf Elias Sallum A; Maria Arruda Campos L; Tomie Kozu K; Borges Vendramini M; Fontoura N; de Souza Azevedo A; Dias Schwarcz W; Marli Christovam Sartori A; Antonangelo L; Artur Silva C; Bonfá E
    Vaccine X; 2022 Apr; 10():100131. PubMed ID: 34977552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine.
    Desai S; Anil K; Potey AV; Sindhu Y; Grappi S; Lapini G; Manney S; Tyagi P; Montomoli E; Poonawalla CS; Kulkarni PS
    NPJ Vaccines; 2022 Dec; 7(1):170. PubMed ID: 36535976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
    Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccinations for international travellers travelling from Greece.
    Pavli A; Spilioti A; Lymperi I; Katerelos P; Maltezou HC
    Travel Med Infect Dis; 2013; 11(4):225-30. PubMed ID: 23433917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.